Vimarsana
Biggest News Aggregation in the World

Immunologic Factors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunologic Factors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunologic Factors Today - Breaking & Trending Today

Data from SOTIO's Phase 1/1b AURELIO-03 Trial of SOT101 Demonstrate Clinical Benefit in Patients with Solid Tumors - Vimarsana News

Data from SOTIO's Phase 1/1b AURELIO-03 Trial of SOT101 Demonstrate Clinical Benefit in Patients with Solid Tumors

Published: May 27, 2022

Data demonstrate that SOT101 monotherapy and SOT101 in combination with pembrolizumab have a favorable safety profileEncouraging efficacy signals were observed for both SOT101 monotherapy and SOT101 in combination with pembrolizumab, even in patients with checkpoint-inhibitor relapsed and refractory tumors15 out of...

Source: pharmiweb.com
Related Topics:
United StatesCzech RepublicComunidad Autonoma De CatalunaElena GarraldaMichael TattoryRadek SpisekRichard KapsaLifesci CommunicationsAmerican Society Of Clinical OncologyVall Dhebron Institute Of OncologyValld Hebron InstituteClinical OncologyAnnual MeetingClinical TrialsMedical OncologyTumor MicroenvironmentImmunologic Factors
Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meetin - Vimarsana News

Oral Presentation of Interim Data from the AURELIO-03 Study of SOT101 at the 2022 ASCO Annual Meetin

Published: April 27, 2022

SOTIO will share interim safety and efficacy results from SOTIO’s AURELIO-03 study on Saturday, June 4AURELIO-03 is a Phase 1/1b dose escalation study of the interleukin-15 superagonist SOT101 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumorsBASEL, Switzerland, April 27, 202...

Source: pharmiweb.com
Related Topics:
United StatesCzech RepublicComunidad Autonoma De CatalunaElena GarraldaMichael TattoryRichard KapsaLifesci CommunicationsAmerican Society Of Clinical OncologyVall Dhebron Institute Of OncologyAmerican SocietyClinical OncologyAnnual MeetingValld Hebron InstitutePresentation DetailsOral AbstractDevelopmental TherapeuticsClinical TrialsMedical OncologyTumor MicroenvironmentImmunologic FactorsTkiller CellsPositivet LymphocytesAdaptive Immunity